Li Kang Biomedical Co Ltd (6242) — Strategic Asset Allocation Index
Li Kang Biomedical Co Ltd (6242) has a Strategic Asset Allocation Index of 46.9% as of June 2023. Strategic assets (PP&E of NT$272.48 Million plus long-term investments of NT$-) total NT$272.48 Million, measured against net assets of NT$580.65 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Li Kang Biomedical Co Ltd Strategic Asset Allocation Index (2002–2022)
This chart shows how Li Kang Biomedical Co Ltd's Strategic Asset Allocation Index has evolved across 21 annual periods from 2002 to 2022. As of June 2023, the index stands at 46.9%, representing strategic assets of NT$272.48 Million against net assets of NT$580.65 Million TWD. Explore cash flow conversion of Li Kang Biomedical Co Ltd to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Li Kang Biomedical Co Ltd (2002–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Li Kang Biomedical Co Ltd from 2002 to 2022, covering 21 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 6242 stock market capitalisation.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 48.5% | NT$276.68 Million | NT$276.68 Million | NT$- | NT$570.14 Million | ▼ -25.1 pp |
| 2021 | 73.7% | NT$362.40 Million | NT$362.40 Million | NT$- | NT$492.00 Million | ▲ +0.7 pp |
| 2020 | 72.9% | NT$370.66 Million | NT$370.66 Million | NT$- | NT$508.30 Million | ▼ -6.5 pp |
| 2019 | 79.5% | NT$384.13 Million | NT$384.13 Million | NT$- | NT$483.44 Million | ▼ -6.5 pp |
| 2018 | 86.0% | NT$401.43 Million | NT$401.43 Million | NT$- | NT$466.92 Million | ▲ +9.2 pp |
| 2017 | 76.8% | NT$342.14 Million | NT$342.14 Million | NT$- | NT$445.68 Million | ▼ -28.2 pp |
| 2016 | 105.0% | NT$357.85 Million | NT$357.85 Million | NT$- | NT$340.80 Million | ▼ -28.2 pp |
| 2015 | 133.2% | NT$373.24 Million | NT$373.24 Million | NT$- | NT$280.29 Million | ▲ +127.3 pp |
| 2014 | 5.9% | NT$13.36 Million | NT$13.36 Million | NT$- | NT$227.44 Million | ▼ -14.5 pp |
| 2013 | 20.4% | NT$4.95 Million | NT$4.95 Million | NT$- | NT$24.29 Million | ▲ +12.7 pp |
| 2012 | 7.7% | NT$6.52 Million | NT$6.52 Million | NT$- | NT$85.12 Million | ▲ +2.2 pp |
| 2011 | 5.4% | NT$6.72 Million | NT$6.72 Million | NT$- | NT$123.43 Million | ▲ +1.1 pp |
| 2010 | 4.3% | NT$4.51 Million | NT$4.51 Million | NT$- | NT$104.31 Million | ▼ -33.4 pp |
| 2009 | 37.8% | NT$48.51 Million | NT$48.51 Million | NT$- | NT$128.49 Million | ▲ +1.0 pp |
| 2008 | 36.7% | NT$70.24 Million | NT$70.24 Million | NT$- | NT$191.32 Million | ▲ +17.7 pp |
| 2007 | 19.0% | NT$78.22 Million | NT$78.22 Million | NT$- | NT$411.54 Million | ▼ -85.1 pp |
| 2006 | 104.1% | NT$224.78 Million | NT$224.78 Million | NT$- | NT$215.94 Million | ▼ -18.0 pp |
| 2005 | 122.1% | NT$272.73 Million | NT$272.73 Million | NT$- | NT$223.45 Million | ▲ +32.9 pp |
| 2004 | 89.2% | NT$288.44 Million | NT$288.44 Million | NT$- | NT$323.44 Million | ▼ -0.9 pp |
| 2003 | 90.1% | NT$304.55 Million | NT$304.55 Million | NT$- | NT$338.06 Million | ▼ -5.0 pp |
| 2002 | 95.1% | NT$330.53 Million | NT$330.53 Million | NT$- | NT$347.64 Million | — |